GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Energenesis Biomedical Co Ltd (TPE:6657) » Definitions » Issuance of Debt

Energenesis Biomedical Co (TPE:6657) Issuance of Debt : NT$0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Energenesis Biomedical Co Issuance of Debt?

Energenesis Biomedical Co's Issuance of Debt for the three months ended in Mar. 2025 was NT$0.00 Mil.

Energenesis Biomedical Co's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0.00 Mil.

Energenesis Biomedical Co Issuance of Debt Historical Data

The historical data trend for Energenesis Biomedical Co's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Energenesis Biomedical Co Issuance of Debt Chart

Energenesis Biomedical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Energenesis Biomedical Co Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Energenesis Biomedical Co Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Energenesis Biomedical Co Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Energenesis Biomedical Co's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Energenesis Biomedical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Energenesis Biomedical Co Ltd (TPE:6657) » Definitions » Issuance of Debt
Comparable Companies
TPE:1760 ROCO:6875 TPE:1734 ROCO:4167 ROCO:7759 ROCO:7832 ROCO:4157 TPE:6949 ROCO:4178 TPE:4142 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 21, Lane 583, Ruiguang Road, 6th Floor -3, Neihu District, Taipei, TWN, 11492
Website
https://www.energenesis-biomedical.com
Energenesis Biomedical Co Ltd is a biomedicine company. It is engaged in businesses related to biological experimentation and analysis, as well as new drug development. The company uses its ENERGI drug development platform to activate AMP-activated protein kinase (AMPK), a key enzyme in cell energy regulation, as a means of developing disease treatments. Its product pipeline consists of ENERGI-F703, a diabetic foot ulcers treatment gel; ENERGI-F701, a product developed for male hair loss; ENERGI-F704, an inflammatory bowel disease treatment; and ENERGI-F711, a burn cream, among others.

Energenesis Biomedical Co Headlines

No Headlines